Advance of research on Hereditary spastic paraplegia type 4.
10.3760/cma.j.cn511374-20221105-00762
- Author:
Jie WANG
1
;
Yaxian LIU
;
Lichun ZHANG
;
Lirong ZHAO
;
Xiaoxia LIU
;
Xiaohua WANG
Author Information
1. Department of Genetics, Inner Mongolia Maternity and Child Health Care Hospital, Hohhot, Inner Mongolia 010020, China. wangxiaohua2222@163.com.
- Publication Type:Journal Article
- MeSH:
Humans;
Spastic Paraplegia, Hereditary/genetics*;
Mutation;
Spastin/genetics*;
Paraplegia/genetics*;
Phenotype
- From:
Chinese Journal of Medical Genetics
2024;41(1):113-119
- CountryChina
- Language:Chinese
-
Abstract:
Spastic paraplegia type 4 (SPG4) is the most common type of autosomally inherited spastic paraplegia. Its main clinical features include typical simple hereditary spastic paraplegia, with neurological impairments limited to lower limb spasticity, hypertonic bladder dysfunction, and mild weakening of lower limb vibration sensation, without accompanying features such as nerve atrophy, ataxia, cognitive impairment, seizures, and muscle tone disorders. SPAST is the main pathogenic gene underlying SPG4, and various pathogenic SPAST variants have been discovered. This disease has featured a high degree of clinical heterogeneity, and the same pathogenic variant can have different age of onset and severity among different patients and even within the same family. There is a lack of systematic research on the correlation between the genotype and phenotype of SPG4, and the pathogenic mechanism has remained controversial. This article has provided a review for the clinical characteristics, pathogenic gene characteristics, correlation between the genotype and phenotype, and pathogenic mechanism of this disease, with an aim to provide reference for its clinical diagnosis and treatment.
